Tuberculosis treatment outcomes and patient support groups, southern India.
Research
Tuberculosis treatment outcomes and patient support groups,
southern India
Rajaram Subramanian Potty,a Karthikeyan Kumarasamy,a Joseph F Munjattu,a Ramesh C Reddy,b
Rajesham Adepu,c Anil Singarajipura,b Mohan H Lakkappa,a Reuben Swamickan,d Amar Shah,d Vikas Panibatlae
& Reynold Washingtonf
Objective To assess treatment outcomes in tuberculosis patients participating in support group meetings in five districts of Karnataka and
Telangana states in southern India.
Methods Tuberculosis patients from five selected districts who began treatment in 2019 were offered regular monthly support group
meetings, with a focus on patients in urban slum areas with risk factors for adverse outcomes. We tracked the patients’ participation in these
meetings and extracted treatment outcomes from the Nikshay national tuberculosis database for the same patients in 2021. We compared
treatment outcomes based on attendance of the support groups meetings.
Findings Of 30 706 tuberculosis patients who started treatment in 2019, 3651 (11.9%) attended support groups meetings. Of patients who
attended at least one support meeting, 94.1% (3426/3639) had successful treatment outcomes versus 88.2% (23 745/26 922) of patients
who did not attend meetings (adjusted odds ratio, aOR: 2.44; 95% confidence interval, CI: 2.10–2.82). The odds of successful treatment
outcomes were higher in meeting participants than non-participants for all variables examined including: age ≥ 60 years (aOR: 3.19; 95%
CI: 2.26–4.51); female sex (aOR: 3.33; 95% CI: 2.46–4.50); diabetes comorbidity (aOR: 3.03; 95% CI: 1.91–4.81); human immunodeficiency
virus infection (aOR: 3.73; 95% CI: 1.76–7.93); tuberculosis retreatment (aOR: 1.69; 1.22–2.33); and drug-resistant tuberculosis (aOR: 1.93;
95% CI: 1.21–3.09).
Conclusion Participation in support groups for tuberculosis patients was significantly associated with successful tuberculosis treatment
outcomes, especially among high-risk groups. Expanding access to support groups could improve tuberculosis treatment outcomes at
the population level.
Introduction
Estimates indicate that India has the largest number of tuberculosis patients (26%) and tuberculosis-related deaths (36%)
in the world.1 India’s success in tackling tuberculosis is critical
to achieving the global goal of ending tuberculosis by 2030.
India’s national strategic plan on tuberculosis 2017–2025 envisages achieving a treatment success rate of 92% and 75% among
individuals with drug-sensitive and drug-resistant tuberculosis, respectively, by 2025.2 Overall, the treatment success rate
for drug-sensitive and drug-resistant tuberculosis was 81%
(1 665 016/2 049 517) and 48% (16 668/34 621), respectively, in
2018.3 These figures highlight the need for highly effective and
rapidly scalable interventions to accelerate the success rate in
tuberculosis treatment outcomes.
Treatment approaches that include patients and their family
members in a person-centred care process are more likely to be
successful.4,5 Processes for empowering and involving tuberculosis patients in the prevention and control of their disease are
of increasing interest to policy-makers, programme managers
and health-care providers concerned with tuberculosis control.6
Many studies on other disease conditions show that empowering and involving patients is feasible using forums that facilitate
sharing and learning from other patients’ experiences, challenges
and successes.6–12 Peer support for tuberculosis patients has been
attempted in many countries with varying degrees of success.13–16
In India, strategies for peer support and patient involvement have
rarely been implemented and studied. In this paper, we describe
implementation of support group meetings for tuberculosis
patients and assess tuberculosis treatment outcomes in patients
participating in these meetings.
Methods
Study setting
The Tuberculosis Health Action Learning Initiative, funded
by the United States Agency for International Development,
was implemented in selected districts of two states in southern
India during 2016–2020. In total, 46 tuberculosis units from
urban areas of Bellary, Bengaluru Urban and Koppal districts
in Karnataka state and Warangal and Hyderabad districts in
Telangana state were selected for the implementation of support
group meetings in 2019. In consultation with state and district
tuberculosis programme staff, districts with higher proportions
of the urban population living in slums were selected.
Karnataka Health Promotion Trust (KHPT), IT Park, Rajajinagar Industrial Area, Behind KSSIDC Administration Office, Rajajinagar, Bengaluru, Karnataka, India 560044.
Office of the Joint Director, Lady Willingdon State TB Centre, Bengaluru, India.
c
Office of the Joint Director, Commissionerate of Health and Family Welfare, Hyderabad, India.
d
Tuberculosis and Infectious Diseases Division, United States Agency for International Development India, New Delhi, India.
e
TB Alert India, Hyderabad, India.
f
St John’s Research Institute, Bengaluru, India.
Correspondence to Rajaram S Potty (email: ).
(Submitted: 4 April 2022 – Revised version received: 14 October 2022 – Accepted: 21 October 2022 – Published online: 15 November 2022 )
a
b
28
Bull World Health Organ 2023;101:28–35A | doi: http://dx.doi.org/10.2471/BLT.22.288237
Research
Tuberculosis treatment outcomes, India
Rajaram Subramanian Potty et al.
Implementation
We locally recruited community health
workers (CHWs) from urban communities in 2016.17 In 2019, senior technical
tuberculosis programme staff and technical
staff of the project trained the CHWs and
tuberculosis programme field staff to jointly
organize and conduct monthly support
group meetings within the public health
facilities offering tuberculosis services.
These health workers and programme staff
formed support groups for tuberculosis
patients who started treatment in 2019.
Family members and/or caregivers of the
patients and individuals who had previously
completed tuberculosis treatment were included in the support groups. Tuberculosis
patients who were very ill were excluded
from participating. Support group members
received information on the date and time
of the meetings from CHWs or the tuberculosis programme staff. Initially, the health
workers or programme staff provided this
information during home or clinic visits.
Later, district tuberculosis programme
managers designated a specific day and time
for the support group meetings and this
information was stamped on the patientheld treatment card. The project provided
CHWs and programme staff with a list of
topics and behaviour change communication materials to facilitate the meetings, and
they encouraged participants to actively interact during the meeting. Topics included
stigma and disclosure, treatment adherence,
nutrition, healthy living and protection of
other family members from tuberculosis.
Each meeting lasted for 60–90 minutes during which participants discussed only one
topic (...truncated)